CUSIP 00288U106COMABCLQ4 2025
19 filings · latest Nov 14, 2024
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Baker Bros. Advisors LP | 27.53M | $94.14M |
| 2 | Capital World Investors | 13.36M | $45.69M |
| 3 | Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas LLC | 7.88M | $26.94M |
| 4 | Two Sigma Investments, LP | 5.81M | $19.87M |
| 5 | Two Sigma Advisers, LP | 4.88M | $16.68M |
| 6 | Goldman Sachs Group Inc | 4.34M | $14.86M |
| 7 | Arrowmark Colorado Holdings LLC | 4.11M | $14.04M |
| 8 | Blackrock, Inc. | 3.87M | $13.22M |
| 4 | Feb 13, 2024 | Hansen Carl L. G. | 13G/A | 20.6% | 60.74M | SEC |
| 5 | Jan 29, 2024 | Baillie Gifford & Co | 13G/A | 8.3% | 24.04M | SEC |
| 6 | Apr 24, 2023 | Thiel Peter | 13D/A | 5.0% | 14.36M | SEC |
| 7 | Feb 13, 2023 | Capital World Investors | 13G/A | 3.3% | 9.33M | SEC |
| 8 | Feb 6, 2023 | Hansen Carl L. G. | 13G/A | 20.4% | 58.99M | SEC |
| 9 | Jan 18, 2023 | Baillie Gifford & Co | 13G | 6.9% | 19.70M | SEC |
| 10 | Feb 14, 2022 | Viking Global Investors LP | 13G/A | — | — | SEC |
See the full Schedule 13D/13G history for Abcellera Biologics Inc.
Unlock full history| 9 |
| Driehaus Capital Management LLC |
| 3.77M |
| $12.90M |
| 10 | Morgan Stanley | 3.00M | $10.27M |